Novartis R&D day spotlights attractive growth profile, underpinned by strong in-market brands, 20 potential high value pipeline assets, and technology platforms
Focused medicines company delivering strong operational performance Building depth in five core therapeutic areas, strength…
Hong Kong connects Malaysian ambition with Asia’s growth opportunities
Value Reassessment in the Cycle – The Long-Term Investment Logic and Risk Boundaries of CMBC Capital (1141.HK)
The Scarce Target of Bank-Owned Investment Banking Platforms – The Shareholder Synergy and Strategic Positioning Value of CMBC Capital
The Resonance of High Dividends and Prudent Capital Management: Defensive Value Revaluation of CMBC Capital (1141.HK)
2026 Fields Medals Awarded to Four of World’s Top Mathematicians